Sites

Study Sponsor: Cleveland Clinic 

Principal Investigator

Amit Anand, MD

“This study will fill the evidence gap around ketamine versus ECT for treatment-resistant depression,”

Baylor College of Medicine

Principal Investigator: Sanjay Mathew, MD

Dr. Mathew is a Professor of Psychiatry and Behavioral Sciences, the Chair for Research in Psychiatry, and the Director of the Mood and Anxiety Disorders Program at Baylor College of Medicine.

If you live in Houston and would like to see if you are eligible for the study, please contact Sidra Iqbal at (713) 689-9856 or email mood@bcm.edu.  You may also contact Dr. Mathew at sjmathew@bcm.edu.

 

 

 

 

 

Cleveland Clinic

Principal Investigator: Roman Dale, MD

Dr. Dale is the Medical Director for Adult and Geriatric Inpatient Services at the Cleveland Clinic.

If you live in Cleveland and would like to see if you are eligible for the study, please contact Kelly Bryant at (216) 363-2492 or anglek@ccf.org.

 

Yale School of Medicine

Principal Investigator: Gerard Sanacora, PhD, MD

Dr. Sanacora is a Professor of Psychiatry and the Medical Director of the Yale Depression Research Program at Yale.

If you live in New Haven and would like to see if you are eligible for the study please contact Jane Wanyiri, RN by phone at (203) 764-9131 or by email at depression.research@yale.edu.

 

 

 

Mount Sinai

Principal Investigator: James Murrough, M

Dr. Murrough is an Assistant Professor in Psychiatry and Director of the Mood and Anxiety Disorders Program at the Icahn School of Medicine at Mount Sinai.

If you live in New York City and would like to see if you are eligible for the study please contact Mora Grehl at (212) 241-8538 or mora.grehl@mssm.edu.